Risk factors associated with IgA vasculitis with nephritis (Henoch-Schönlein purpura nephritis) progressing to unfavorable outcomes: A meta-analysis

PLoS One. 2019 Oct 1;14(10):e0223218. doi: 10.1371/journal.pone.0223218. eCollection 2019.

Abstract

Objective: To identify risk factors associated with unfavorable outcomes in children with IgA vasculitis with nephritis (Henoch-Schőnlein purpura nephritis)(IgA-VN).

Methods: PubMed, Embase, and Web of Science databases were searched for studies, published in English through February 2019. The data were extracted to perform pooled analysis, heterogeneity testing, subgroup analysis, sensitivity analysis, and publication bias analysis.

Results: This meta-analysis showed that, older age at onset (WMD 1.77, 95% CI 0.35-3.18, p = 0.014), lower glomerular filtration rate (GFR; WMD -23.93, 95% CI -33.78- -14.09, p<0.0001), initial renal manifestations with nephrotic syndrome (OR 1.74, 95% CI 1.12-2.70, p = 0.013), with nephritic-nephrotic syndrome (OR 4.55, 95% CI 2.89-7.15, p<0.0001) and renal biopsy with crescentic nephritis (International Study of Kidney Disease in Children [ISKDC] grades III-V) (OR 3.85, 95% CI 2.37-6.28, p<0.0001) were significant risk factors associated with poor outcomes in IgA-VN, whereas initial clinical features with hematuria (OR 0.33, 95% CI 0.16-0.69, p = 0.003) and mild proteinuria±hematuria (OR 0.46, 95% CI 0.28-0.75, p<0.0001) were associated with progression to good outcomes. By contrast, gender, hypertension and initial renal manifestations of acute nephritic syndrome were not significantly associated with poor outcomes in IgA-VN.

Conclusion: This meta-analysis showed that older age at onset, lower GFR, initial renal features of nephrotic syndrome and nephritic-nephrotic syndrome and renal biopsy with crescentic nephritis (ISKDC grades III-V) were predictive of poor prognosis in children with IgA-VN.

Publication types

  • Meta-Analysis

MeSH terms

  • Biopsy
  • Female
  • Glomerular Filtration Rate / immunology
  • Humans
  • IgA Vasculitis / complications
  • IgA Vasculitis / epidemiology*
  • IgA Vasculitis / immunology
  • IgA Vasculitis / physiopathology
  • Immunoglobulin A / immunology*
  • Kidney / immunology
  • Kidney / physiopathology
  • Male
  • Nephritis / complications
  • Nephritis / epidemiology*
  • Nephritis / immunology
  • Nephritis / physiopathology
  • Proteinuria / complications
  • Proteinuria / immunology
  • Proteinuria / physiopathology
  • Risk Factors
  • Vasculitis / complications
  • Vasculitis / epidemiology*
  • Vasculitis / immunology
  • Vasculitis / physiopathology

Substances

  • Immunoglobulin A

Grants and funding

The authors received no specific funding for this work.